Skip to content

Impact of the Lab-score on Antibiotic Prescription Rate in Children With Fever Without Source

Impact of the Lab-score on Antibiotic Prescription Rate in Children Aged 7 Days to 3 Years Old With Fever Without Source.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02179398
Enrollment
278
Registered
2014-07-01
Start date
2010-09-30
Completion date
2013-07-31
Last updated
2014-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fever Without Source

Keywords

Fever without source, Antibiotic prescription, Serious bacterial infection

Brief summary

Detecting serious bacterial infections (SBI) in children presenting to the Pediatric Emergency Department (PED) with fever without source (FWS) is a frequent diagnostic challenge. The recently described Lab-score, based on the combined determination of Procalcitonin, C-Reactive Protein (CRP) and urine dipstick results, has been shown an accurate tool for SBI prediction on retrospective cohorts. The investigators aimed to assess the usefulness of the Lab-score in safely decreasing unnecessary antibiotic prescriptions in children with FWS, and to prospectively determine the diagnostic characteristics of the Lab-score compared to other classically used SBI biomarkers (white blood cell (WBC) count, band count and CRP).

Interventions

BIOLOGICALAllocation to the Lab-score group
BIOLOGICALAllocation to the control group

Sponsors

BioMérieux
CollaboratorINDUSTRY
University Hospital, Geneva
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
7 Days to 3 Years
Healthy volunteers
No

Inclusion criteria

* children aged 7 days to 3 years old * fever without source ≥ 100.4°F (≥ 38.0°C)

Exclusion criteria

* antibiotics received in the previous 48 hours * underlying congenital or acquired immunodeficiency syndrome * fever for more than 7 days at presentation

Design outcomes

Primary

MeasureTime frame
Antibiotic Prescription Rateat PED (Pediatric Emergency Department) presentation

Secondary

MeasureTime frameDescription
Presence of Serious Bacterial Infectionat 72 hours from PED presentation
Hospitalization Rateat PED presentation
Specificity of Standard Biological Marker for SBIat 72 hours from PED presentationSpecificity of standard biological marker for SBI: WBC ≥ 15'000/mm³ and/or bands ≥ 1'500/mm³ and/or CRP ≥ 40 mg/L
Specificity of a Lab-score ≥ 3at 72 hours from PED presentation
Sensitivity of Standard Biological Marker for SBIat 72 hours from PED presentationSensitivity of standard biological marker for SBI: WBC ≥ 15'000/mm³ and/or bands ≥ 1'500/mm³ and/or CRP ≥ 40 mg/L
Sensitivity of a Lab-score ≥ 3at 72 hours from PED presentation

Countries

Switzerland

Participant flow

Participants by arm

ArmCount
Lab-score Group
Patients assessed through the Lab-score determination only: Lab-score ≥3 used as the sole marker for the detection of serious bacterial infection. (WBC and band counts blinded to the physician in charge of the patient) Allocation to the Lab-score group
131
Control Group
Patients assessed through the following classically admitted biomarkers for the detection of serious bacterial infection: WBC count, band count and CRP determination. (PCT and thus Lab-score blinded to the physician in charge of the patient). Allocation to the control group
140
Total271

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLack of obligatory data33
Overall StudyLost to Follow-up01

Baseline characteristics

CharacteristicLab-score GroupControl GroupTotal
Age, Continuous4.8 months3.4 months4.0 months
Fever duration
12-24 hours
25 participants24 participants49 participants
Fever duration
< 12 hours
47 participants55 participants102 participants
Fever duration
> 24 hours
59 participants61 participants120 participants
Lab-score value2.03 units on a scale
STANDARD_DEVIATION 2.62
2.04 units on a scale
STANDARD_DEVIATION 2.86
2.04 units on a scale
STANDARD_DEVIATION 2.74
Maximum temperature39.3 °C
STANDARD_DEVIATION 0.8
39.3 °C
STANDARD_DEVIATION 0.8
39.3 °C
STANDARD_DEVIATION 0.78
Presence of Serious Bacterial Infection (SBI)32 participants35 participants67 participants
Sex: Female, Male
Female
66 Participants69 Participants135 Participants
Sex: Female, Male
Male
65 Participants71 Participants136 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1310 / 140
serious
Total, serious adverse events
0 / 1310 / 140

Outcome results

Primary

Antibiotic Prescription Rate

Time frame: at PED (Pediatric Emergency Department) presentation

Population: children 7 days - 36 months old presenting to the PED with fever without source (FWS) ≥38.0°C (≥ 100.4°F) after a thorough history and careful examination

ArmMeasureValue (NUMBER)
Lab-score GroupAntibiotic Prescription Rate54 participants
Control GroupAntibiotic Prescription Rate59 participants
p-value: 1Chi-squared
Secondary

Hospitalization Rate

Time frame: at PED presentation

ArmMeasureValue (NUMBER)
Lab-score GroupHospitalization Rate44 participants
Control GroupHospitalization Rate50 participants
Comparison: Power calculation suggested 97 patients should be enrolled in each group to give 80% power at the 5% level of significance to detect a 20% difference in antibiotic prescription ratep-value: 0.81Chi-squared
Secondary

Presence of Serious Bacterial Infection

Time frame: at 72 hours from PED presentation

ArmMeasureValue (NUMBER)
Lab-score GroupPresence of Serious Bacterial Infection32 participants
Control GroupPresence of Serious Bacterial Infection35 participants
p-value: 1Chi-squared
Secondary

Sensitivity of a Lab-score ≥ 3

Time frame: at 72 hours from PED presentation

ArmMeasureValue (NUMBER)
Lab-score GroupSensitivity of a Lab-score ≥ 385.1 percentage of patients (sensitivity)
Control GroupSensitivity of a Lab-score ≥ 380.0 percentage of patients (sensitivity)
Secondary

Sensitivity of Standard Biological Marker for SBI

Sensitivity of standard biological marker for SBI: WBC ≥ 15'000/mm³ and/or bands ≥ 1'500/mm³ and/or CRP ≥ 40 mg/L

Time frame: at 72 hours from PED presentation

ArmMeasureValue (NUMBER)
Lab-score GroupSensitivity of Standard Biological Marker for SBI83.6 percentage of patients (sensitivity)
Control GroupSensitivity of Standard Biological Marker for SBI70.0 percentage of patients (sensitivity)
Secondary

Specificity of a Lab-score ≥ 3

Time frame: at 72 hours from PED presentation

ArmMeasureValue (NUMBER)
Lab-score GroupSpecificity of a Lab-score ≥ 387.3 percentage of patients (specificity)
Control GroupSpecificity of a Lab-score ≥ 393.1 percentage of patients (specificity)
Secondary

Specificity of Standard Biological Marker for SBI

Specificity of standard biological marker for SBI: WBC ≥ 15'000/mm³ and/or bands ≥ 1'500/mm³ and/or CRP ≥ 40 mg/L

Time frame: at 72 hours from PED presentation

ArmMeasureValue (NUMBER)
Lab-score GroupSpecificity of Standard Biological Marker for SBI68.8 percentage of patients (specificity)
Control GroupSpecificity of Standard Biological Marker for SBI79.3 percentage of patients (specificity)

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026